Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a smartphone app ease the burden on Alzheimer's caregivers?

NCT ID NCT07764185

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 13, 2026 · Last updated Aug 21, 2026 · Updated 2 times

Summary

This study tests whether a mobile app-based behavioral therapy, called Recharge, can help reduce stress and depressive symptoms in people who care for someone with Alzheimer's disease or related dementias. Caregivers aged 18 and older who spend at least 8 hours per week caring for a loved one with dementia may participate. Half will use the Recharge app, while the other half will receive a traditional educational program, and researchers will compare changes in stress and depression levels between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Recharge Behavioral Therapy delivered via a mobile app
What this could lead to
If effective, this app-based therapy could offer a practical, accessible way to reduce stress and depressive symptoms for the millions of people caring for loved ones with Alzheimer's disease.
What could go wrong
This is a phase 2 trial with 150 participants, so results are preliminary. The therapy may not outperform a traditional educational program, and individual outcomes may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 150 people

The number the study aims to enrol. It can still change while the study runs.

Started

Aug 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Care for an individual with Alzheimer s Disease or other dementia. * Have a Smartphone or tablet with Internet access. * Minimum age of 18 years old. * Spend at least 8 hours/week caring for a person with dementia. Exclusion Criteria: * Severe psychological or physical illness. * Inability to read and follow instructions. * Unwillingness to participate in all aspects of the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver stress are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Caregiver Burden

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Photozig, Inc.

    RECRUITING

    Campbell, California, 95008, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.